Energy Balance Pathways: Studying integrated metabolic response mechanisms
Unlike existing GLP-1 therapies, which are peptide-based and require injections, orforglipron is a synthetic, non-peptide small molecule: orally bioavailable, once-daily, and independent of food or water intake
Pediatr Res 47:1723
During the Hims Q3 2024 earnings call, CEO and Co-Founder Andrew Dudum pointed to customization aimed at mitigating side effects as justification for the company to continue compounding drugs for weight loss once the shortage is resolved
For more on the longevity market: Behind the scenes of this tech millionaires Dont Die summit as extreme biohacking becomes a dominant wellness trend Actress Halle Berry is ready for her second act, as she becomes a major player in the $17 billion menopause market 5 ways to reduce your dementia risk as study estimates U.S
Another rat model revealed VNS increased the number of mast cells in the GI wall and c-Fos expression in nodosal ganglia